Quantile Capital Acquires a Rival: Accretive or Not?
Finance
medium55 min0 submissionsRazorpay
Scenario
Quantile Capital (asset management, UK) is considering acquiring a smaller competitor.
Acquirer. Net income of £119 M, 132 million shares outstanding, trading at £63 per share. Current EPS is therefore £0.90.
Target. Net income of £32 M, currently valued by the market at £1083 M. The board expects to pay a 24% premium to that price.
Management projects £34 M of annual run-rate synergies, roughly 79% of which are cost synergies from overlapping sales and back-office functions, with the remainder from cross-selling. One-time integration costs are estimated at £28 M.
The deal would be financed with debt at 7.4%. The marginal tax rate is 25%.
Supporting data
deal
- tax rate pct
- 25
- debt rate pct
- 7.4
- integration cost m
- 28
- run rate synergies m
- 34
target
- premium pct
- 24
- net income m
- 32
- market value m
- 1083
acquirer
- eps
- 0.9
- share price
- 63
- net income m
- 119
- shares outstanding
- 132
Your task
Advise the board on whether to proceed. Provide:
- Analysis — accretion/dilution to EPS in year one and at full synergy run-rate.
- Risks — what would make this deal destroy value.
- Recommendation — proceed, renegotiate, or walk. Specify price and structure.
Ready to move forward? Up next: Solstice Travel: Is This Target Growing, or Just Floating?Next question
How you'll be graded
100 points, 60% to pass.
- deal analysis25
- recommendation25
- risk assessment25
- synergy assessment25
Hint
Reveal suggested structure
- Purchase price = market value × (1 + premium).
- Financing cost = purchase price × debt rate, then after tax.
- Combined earnings = acquirer + target + after-tax synergies − after-tax interest.
- Combined EPS = combined earnings ÷ share count (unchanged in an all-cash deal).
- Compare against standalone EPS. Do this for year 1 (partial synergies, integration costs) and steady state.
- Sanity check the price against the target's standalone value.